uniQure call volume above normal and directionally bullish
PremiumThe FlyuniQure call volume above normal and directionally bullish
15d ago
Unusually active option classes on open July 10th
PremiumThe Fly
Unusually active option classes on open July 10th
17d ago
uniQure a ‘mispriced’ gene therapy company, says Guggenheim
PremiumThe Fly
uniQure a ‘mispriced’ gene therapy company, says Guggenheim
17d ago
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
PremiumPress ReleasesuniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
18d ago
uniQure’s Strategic Asset Sale and Financial Maneuvers
PremiumCompany Announcements
uniQure’s Strategic Asset Sale and Financial Maneuvers
26d ago
uniQure to sell commercial manufacturing facility to Genezen for $25M
PremiumThe Fly
uniQure to sell commercial manufacturing facility to Genezen for $25M
26d ago
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
PremiumPress ReleasesuniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
2M ago
uniQure receives RMAT designation of AMT-130 in Huntington’s Disease
PremiumThe Fly
uniQure receives RMAT designation of AMT-130 in Huntington’s Disease
2M ago
uniQure price target lowered to $25 from $28 at Leerink
PremiumThe Fly
uniQure price target lowered to $25 from $28 at Leerink
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100